Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer

Background. Immunotherapy has shown efficacy in small cell lung cancer (SCLC), but only a subset of patients benefits. Surrogate biomarkers are urgently needed. Our aim was to evaluate serum Th1, Th2, and proinflammatory cytokines in two cohorts of SCLC patients before and during treatment with chem...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncoimmunology
Main Authors: Hardy-Werbin, Max, Rocha, Pedro, Arpi, Oriol, Taus, Álvaro, Nonell, Lara, Durán, Xavier, Villanueva, Xavier, Joseph-Pietras, Deborah, Nolan, Luke, Danson, Sarah, Griffiths, Richard, Lopez-Botet, Miguel, Rovira, Ana, Albanell, Joan, Ottensmeier, Christian, Arriola, Edurne
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis 2019
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492977/
https://ncbi.nlm.nih.gov/pubmed/31069160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1593810
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker